Axenoll Life Sciences AG

Axenoll 3D Printing GmbH develops and implements projects for cellular 3D screen printing of biomaterials for applications in the medical and biotechnological sector.

Learn more

Laxxon Medical AG

Laxxon Medical AG owns the exclusive global rights for development, production, and commercialization of an innovative new drug delivery system for the controlled release of pharmaceutical actives. This new process is based on a patented 3D printing process.

Learn more

saniva diagnostics GmbH

Saniva diagnostics GmbH develops Neuromex a screening instrument (hardware and software), based on the Falling-Stick-Test enabling the early-stage detection of neurodegenerative diseases, before clinical manifestation of the disease.

Learn more

Vitruvia AG

Learn more